Skip to main content

Table 1 (abstract O33). Estimated Number of Menstrual-Related Migraine Headache Days

From: 12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches

Period Treatment N Estimated Number of MRMHDs per 30 day Period (SE) 95% CI Rate Ratio per 30 day period 95% CI P-value
ITT patients with baseline number of MRMHDs >0 for Episodic Migraine
 Average of Month 1 to 6 PBO 321 1.58 (0.13) 1.34, 1.86    
120mg 170 1.16 (0.12) 0.96, 1.41 0.74 0.64, 0.85 <0.001
240mg 159 1.12 (0.12) 0.90, 1.38 0.71 0.60, 0.83 <0.001
ITT patients with baseline number of MRMHDs >0 for Chronic Migraine
 Average of Month 1 to 3 PBO 198 3.52 (0.18) 3.18, 3.90    
120mg 112 2.58 (0.21) 2.58, 3.40 0.84 0.73, 0.97 0.015
240mg 97 3.01 (0.20) 2.64, 3.42 0.85 0.75, 0.98 0.021
  1. MRMHD Menstrual-Related Migraine Headache Days, CI confidence interval, ITT intent-to-treat, MM menstrual migraine, PBO placebo, SE standard error